TY - JOUR KW - Aged KW - Antimony Sodium Gluconate KW - Antiprotozoal Agents KW - Humans KW - Leishmaniasis KW - Male KW - Mucous Membrane KW - Otorhinolaryngologic Diseases KW - Saudi Arabia AU - Al-Qahtani MS AU - Malik NW AU - Jamil S AU - Mekki TE AB -
Leishmaniasis is caused by Leishmania protozoa. It is widely present in more than 88 countries worldwide, resulting in up to 80,000 deaths annually. Leishmaniasis occurs as visceral, cutaneous, or mucocutaneous variants. Mucosal involvement can occur secondarily to the cutaneous or visceral varieties. However, primary mucosal leishmaniasis (PML) occurs without any present or past cutaneous and or visceral disease. It is extremely rare, and its diagnosis may present a serious challenge. It may be difficult to differentiate it from granulomatous conditions like tuberculosis, sarcoidosis, leprosy, fungal infections, Wegener's granuloma, and neoplasms. Here, we present a case of PML in Saudi Arabia.
BT - Saudi medical journal C1 - http://www.ncbi.nlm.nih.gov/pubmed/23147884?dopt=Abstract DA - 2012 Nov IS - 11 J2 - Saudi Med J LA - eng N2 -Leishmaniasis is caused by Leishmania protozoa. It is widely present in more than 88 countries worldwide, resulting in up to 80,000 deaths annually. Leishmaniasis occurs as visceral, cutaneous, or mucocutaneous variants. Mucosal involvement can occur secondarily to the cutaneous or visceral varieties. However, primary mucosal leishmaniasis (PML) occurs without any present or past cutaneous and or visceral disease. It is extremely rare, and its diagnosis may present a serious challenge. It may be difficult to differentiate it from granulomatous conditions like tuberculosis, sarcoidosis, leprosy, fungal infections, Wegener's granuloma, and neoplasms. Here, we present a case of PML in Saudi Arabia.
PY - 2012 SP - 1234 EP - 8 T2 - Saudi medical journal TI - Diagnostic dilemma of primary mucosal leishmaniasis. VL - 33 SN - 0379-5284 ER -